Global pharmacogenomics: where is the research taking us?

Pharmacogenomics knowledge and technologies, which couple genomics information with pharmaceutical drug response, have been promised to revolutionise ...
405KB Sizes 0 Downloads 3 Views

Recommend Documents

Under the Cartagena Protocol on Biosafety - Where is the Roadmap for Risk Assessment Taking Us?
The paper summarizes the history of the development of the guidance on risk assessment, including the roadmap under the Cartagena Protocol on Biosafety since 2008 until now. The aim and the contents of the roadmap for risk assessment of living modifi

Pharmacogenomics in dermatology: Taking patient treatment to the next level.
The notion of treating the patient, and not the particular disease, has been emphasized by physicians for some time. In the past decade, this idea advanced with the human genome project, and has been taken further with the advent of personalized derm

Myopia, an underrated global challenge to vision: where the current data takes us on myopia control.
Myopia is the most frequent cause of distance impairment in the world and is creating an alarming global epidemic with deleterious ramifications for the quality of life and economic health of individuals and nations as a whole. In addition to being i

Building Global Capacity for Conducting Operational Research Using the SORT IT Model: Where and Who?
Research capacity is weakest in low and middle-income countries (LMICs) where operational research is highly relevant and needed. Structured Operational Research and Training Initiative (SORT IT) courses have been developed to train participants to c

Research that Helps Move Us Closer to a World where Each Child Thrives.
Schools are curtailing programs in arts, physical exercise, and play so more time and resources can be devoted to academic instruction. Yet indications are that the arts (e.g., music, dance, or theatre) and physical activity (e.g., sports, martial ar

Prenatal pharmacogenomics: a promising area for research.
Clinical applications of prenatal genetic screening currently focus on detection of aneuploidy and other genetic diseases in the developing fetus. Growing evidence suggests that the fetal genome may also be informative about fetal exposures through c